Work

Reply to “Rationalizing and mitigating the risk of live-attenuated dengue vaccines”

Year: 2025

Type: letter

Abstract: Thank you for sharing the letter discussing our recently published case report, “Severe dengue hemorrhagic fever after TAK-003 dengue vaccination: A case report of a potential vaccine-associated adverse reaction” [1]. We appreciate the authors’ thoughtful analysis and their comparison with yellow fever vaccine–associated viscerotropic disease (YEL-AVD).

Source: International Journal of Infectious Diseases

DOI: 10.1016/j.ijid.2025.108243

Author: Pinyo Rattanaumpawan

Institutions: Siriraj Hospital, Mahidol University

Language: English

Topic: Mosquito-borne diseases and control

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,900

OpenAlex ID: W4416528168

Cites: 5

Cited by: 1

Related to: